“INVESTIGATING LONG-TERM SIDE EFFECTS OF SNRI: VENLAFAXINE, DULOXETINE, DESVENLAFAXINE, MILNACIPRAN, AND LEVOMILNACIPRAN ANTIDEPRESSANTS TREATMENT IN PATIENTS DIAGNOSED WITH DEPRESSION”, IJITSS, vol. 2, no. 1(49), Mar. 2026, doi: 10.31435/ijitss.1(49).2026.4659.